325 related articles for article (PubMed ID: 34649078)
21. SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
Jarlhelt I; Nielsen SK; Jahn CXH; Hansen CB; Pérez-Alós L; Rosbjerg A; Bayarri-Olmos R; Skjoedt MO; Garred P
Front Immunol; 2021; 12():767981. PubMed ID: 34804055
[TBL] [Abstract][Full Text] [Related]
22. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020.
Sermet-Gaudelus I; Temmam S; Huon C; Behillil S; Gajdos V; Bigot T; Lurier T; Chrétien D; Backovic M; Delaunay-Moisan A; Donati F; Albert M; Foucaud E; Mesplées B; Benoist G; Faye A; Duval-Arnould M; Cretolle C; Charbit M; Aubart M; Auriau J; Lorrot M; Kariyawasam D; Fertitta L; Orliaguet G; Pigneur B; Bader-Meunier B; Briand C; Enouf V; Toubiana J; Guilleminot T; van der Werf S; Leruez-Ville M; Eloit M
Euro Surveill; 2021 Apr; 26(13):. PubMed ID: 33797390
[TBL] [Abstract][Full Text] [Related]
23. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C).
Kuypers FA; Rostad CA; Anderson EJ; Chahroudi A; Jaggi P; Wrammert J; Mantus G; Basu R; Harris F; Hanberry B; Camacho-Gonzalez A; Manoranjithan S; Vos M; Brown LA; Morris CR
Exp Biol Med (Maywood); 2021 Dec; 246(23):2543-2552. PubMed ID: 34255566
[TBL] [Abstract][Full Text] [Related]
24. Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19.
Singh V; Obregon-Perko V; Lapp SA; Horner AM; Brooks A; Macoy L; Hussaini L; Lu A; Gibson T; Silvestri G; Grifoni A; Weiskopf D; Sette A; Anderson EJ; Rostad CA; Chahroudi A
JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35044955
[TBL] [Abstract][Full Text] [Related]
25. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.
Weisberg SP; Connors TJ; Zhu Y; Baldwin MR; Lin WH; Wontakal S; Szabo PA; Wells SB; Dogra P; Gray J; Idzikowski E; Stelitano D; Bovier FT; Davis-Porada J; Matsumoto R; Poon MML; Chait M; Mathieu C; Horvat B; Decimo D; Hudson KE; Zotti FD; Bitan ZC; La Carpia F; Ferrara SA; Mace E; Milner J; Moscona A; Hod E; Porotto M; Farber DL
Nat Immunol; 2021 Jan; 22(1):25-31. PubMed ID: 33154590
[TBL] [Abstract][Full Text] [Related]
26. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
27. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
[TBL] [Abstract][Full Text] [Related]
28. Antibody Response After SARS-CoV-2 Infection and Implications for Immunity : A Rapid Living Review.
Arkhipova-Jenkins I; Helfand M; Armstrong C; Gean E; Anderson J; Paynter RA; Mackey K
Ann Intern Med; 2021 Jun; 174(6):811-821. PubMed ID: 33721517
[TBL] [Abstract][Full Text] [Related]
29. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.
Zeng F; Dai C; Cai P; Wang J; Xu L; Li J; Hu G; Wang Z; Zheng F; Wang L
J Med Virol; 2020 Oct; 92(10):2050-2054. PubMed ID: 32383183
[TBL] [Abstract][Full Text] [Related]
30. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
31. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Qu J; Wu C; Li X; Zhang G; Jiang Z; Li X; Zhu Q; Liu L
Clin Infect Dis; 2020 Nov; 71(16):2255-2258. PubMed ID: 32337590
[TBL] [Abstract][Full Text] [Related]
32. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
33. Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy.
Gontu A; Srinivasan S; Salazar E; Nair MS; Nissly RH; Greenawalt D; Bird IM; Herzog CM; Ferrari MJ; Poojary I; Katani R; Lindner SE; Minns AM; Rossi R; Christensen PA; Castillo B; Chen J; Eagar TN; Yi X; Zhao P; Leveque C; Olsen RJ; Bernard DW; Gollihar J; Kuchipudi SV; Musser JM; Kapur V
Commun Biol; 2021 Feb; 4(1):267. PubMed ID: 33627795
[TBL] [Abstract][Full Text] [Related]
34. Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19.
Thiriard A; Meyer B; Eberhardt CS; Loevy N; Grazioli S; Adouan W; Fontannaz P; Marechal F; L'Huillier AG; Siegrist CA; Georges D; Putignano A; Marchant A; Didierlaurent AM; Blanchard-Rohner G
Front Immunol; 2023; 14():1107156. PubMed ID: 37006315
[TBL] [Abstract][Full Text] [Related]
35. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.
Boppana S; Qin K; Files JK; Russell RM; Stoltz R; Bibollet-Ruche F; Bansal A; Erdmann N; Hahn BH; Goepfert PA
PLoS Pathog; 2021 Jul; 17(7):e1009761. PubMed ID: 34270631
[TBL] [Abstract][Full Text] [Related]
37. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
Carter MJ; Fish M; Jennings A; Doores KJ; Wellman P; Seow J; Acors S; Graham C; Timms E; Kenny J; Neil S; Malim MH; Tibby SM; Shankar-Hari M
Nat Med; 2020 Nov; 26(11):1701-1707. PubMed ID: 32812012
[TBL] [Abstract][Full Text] [Related]
38. Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children.
Burns MD; Bartsch YC; Davis JP; Boribong BP; Loiselle M; Kang J; Kane AS; Edlow AG; Fasano A; Alter G; Yonker LM
Pediatr Res; 2023 Oct; 94(4):1327-1334. PubMed ID: 37173406
[TBL] [Abstract][Full Text] [Related]
39. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of Immunoglobulin M and G Antibodies against SARS-CoV-2 Virus: A Systematic Review and Meta-Analysis Study.
Fathi M; Vakili K; Sayehmiri F; Mohamadkhani A; Ghanbari R; Hajiesmaeili M; Rezaei-Tavirani M
Iran J Immunol; 2021 Mar; 18(1):34-46. PubMed ID: 33787512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
